AI Article Synopsis
- The study aimed to evaluate the effectiveness of combining Q-switched Nd:YAG non-ablative fractionated lasers with intense pulsed light in treating patients with stubborn melasma.
- This combination appears to be the most effective approach for addressing hyperpigmentation caused by melasma, with minimal side effects reported.
- The low incidence of side effects is likely due to the targeted treatment effect at a subcellular level, known as selective photothermolysis.
Article Abstract
The purpose of our study was to verify the results of the association of Q-switched Nd: YAG non-ablative fractionated with intense pulsed light, in order to treat patients with refractory melasma. The combination of these two devices seems to be the best treatment to combat hyperpigmentation produced by melasma, with low occurrence of side effects, which may be justified by the selective photothermolysis at subcellular level.
Download full-text PDF |
Source |
|---|---|
| http://dx.doi.org/10.1111/dth.12250 | DOI Listing |
Publication Analysis
Top Keywords
Similar Publications
Efficacy and Safety of Combination Therapy of Microneedling Radiofrequency, In-Office and Home-Based Topical Cysteamine in Refractory Melasma: A Split Face, Vehicle-Control, Randomized Control Trial.
J Cosmet Dermatol
November 2024
School of Medicine, College of Medicine, Chang Gung University, Taoyuan, Taiwan.
Background: Refractory melasma remains a challenge in dermatology, necessitating the exploration of innovative treatments.
Aims: This study aims to evaluate the efficacy and safety of combining radiofrequency microneedling (RFM) with Cysteamine cream, applied both in-office and as a part of a home-care regimen, to treat refractory melasma.
Patients/methods: A vehicle-controlled, split-face trial was conducted on 30 Fitzpatrick skin types III and IV participants.
Refractory solar lentigines successfully treated with 532-nm nanosecond Nd:YAG Vasculature Salvage Laser Surgery (VSLS) system: Case series.
Skin Res Technol
September 2024
Department of Dermatology, College of Medicine, Chung-Ang University, Seoul, Republic of Korea.
Article Synopsis
- - Solar lentigo is a common skin condition caused by sun exposure, characterized by increased melanocyte activity and melanin accumulation, which can lead to complications from traditional treatments like prolonged redness and hyperpigmentation.
- - In a study involving six Korean patients, the Vasculature Salvage Laser Surgery (VSLS) system, using a specific laser technique, was employed to treat solar lentigo in a single session with follow-ups from 3 to 10 weeks.
- - Results showed complete removal of the lesions with no post-inflammatory hyperpigmentation and only mild temporary redness as a side effect, indicating that VSLS may be a safer and more effective option, although further research is needed for long-term evaluation.
Hyaluronic acid dissolving microneedle patch loaded with tranexamic acid for melasma treatment.
Int J Biol Macromol
June 2024
Shanghai Key Laboratory of Pancreatic Diseases, Precision Research Center for Refractory Diseases in Shanghai General Hospital, Shanghai Jiao Tong University School of Medicine, Shanghai, China. Electronic address:
Melasma is an acquired hypermelanotic condition characterized by the presence of irregular light-to-dark brown macules that primarily manifest on the sun-exposed areas of the skin, particularly the face. The management of melasma poses significant challenges, as it is often recalcitrant to treatment and tends to recur despite successful treatment. In this study, we explored a safe, easy, and effective melasma treatment strategy.
View Article and Find Full Text PDFDefinition of refractory melasma and its treatment: a review.
Lasers Med Sci
April 2024
Department of Dermatology, Hangzhou Third People's Hospital, Affiliated to Zhejiang Chinese Medical University, Hangzhou, China.
Article Synopsis
- The review identified 35 relevant publications and suggests that a combination of laser treatments with other therapies, like oral tranexamic acid (TXA), may offer better outcomes for refractory melasma.
- It emphasizes the need for cautious treatment plans and the importance of maintenance therapy after the initial treatment to ensure lasting results.
755-nm picosecond laser plus topical 20% azelaic acid compared to topical 20% azelaic acid alone for the treatment of melasma: a randomized, split-face and controlled trial.
Lasers Med Sci
April 2024
Department of Dermatology, China-Japan Friendship Hospital, Capital Medical University, NO.2 Yinghua East Road, Chaoyang District, Beijing, China.
Article Synopsis
- This study investigates the effectiveness of 20% azelaic acid cream alone and in combination with 755-nm picosecond laser therapy for treating facial melasma over a 24-week period.
- Conducted with 30 participants, researchers measured treatment efficacy using various assessments, including the mMASI score, dermoscopy, and patient satisfaction.
- Results showed significant improvement in melasma symptoms with both treatments, but no notable clinical differences arose from the combination therapy, although some subtle differences were detected through advanced imaging techniques.
Want AI Summaries of new PubMed Abstracts delivered to your In-box?
Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!